We are live on ! Find out more
Chevy Chase Trust

Chevy Chase Trust Portfolio holdings

AUM $34.7B
1-Year Est. Return 29.45%
This Fund
S&P 500
This Quarter Est. Return
+22.49%
1 Year Est. Return
+29.45%
3 Year Est. Return
+102.04%
5 Year Est. Return
+142.29%
10 Year Est. Return
+523.99%
AUM
$24.7B
AUM Growth
+$3.17B
Cap. Flow
-$1.16B
Cap. Flow %
-4.72%
Top 10 Hldgs %
26.96%
Holding
661
New
31
Increased
56
Reduced
513
Closed
20

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$73.5M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$27.2M
3
DXCM icon
DexCom
DXCM
+$26.6M
4
TMUS icon
T-Mobile US
TMUS
+$18.9M
5
ASML icon
ASML
ASML
+$18.5M

Sector Composition

Rank Sector Weight
1 Technology 24.7%
2 Healthcare 15.1%
3 Financials 12.84%
4 Communication Services 10.4%
5 Consumer Discretionary 10.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHR icon
51
Danaher
DHR
$141B
$115M 0.46%
730,965
-58,236
-7% -$8.36M
BMY icon
52
Bristol-Myers Squibb
BMY
$129B
$110M 0.45%
1,877,091
-166,650
-8% -$9.97M
C icon
53
Citigroup
C
$216B
$103M 0.42%
2,011,507
-987,702
-33% -$46.9M
AVGO icon
54
Broadcom
AVGO
$1.79T
$102M 0.41%
3,237,610
-154,340
-5% -$4.32M
MDT icon
55
Medtronic
MDT
$112B
$99.1M 0.4%
1,080,649
-60,304
-5% -$5.78M
CVS icon
56
CVS Health
CVS
$138B
$98.5M 0.4%
1,516,099
-77,276
-5% -$4.87M
ORCL icon
57
Oracle
ORCL
$339B
$95.5M 0.39%
1,728,357
-168,412
-9% -$8.92M
UNP icon
58
Union Pacific
UNP
$173B
$95.3M 0.39%
563,459
-44,126
-7% -$7.07M
TXN icon
59
Texas Instruments
TXN
$247B
$94.4M 0.38%
743,564
-56,260
-7% -$6.56M
AMT icon
60
American Tower
AMT
$80.9B
$92.6M 0.38%
358,086
-19,634
-5% -$4.86M
TJX icon
61
TJX Companies
TJX
$178B
$92.2M 0.37%
1,823,418
-69,947
-4% -$3.51M
MSCI icon
62
MSCI
MSCI
$42.5B
$91.7M 0.37%
274,801
-11,431
-4% -$3.7M
LIN icon
63
Linde
LIN
$234B
$90M 0.37%
424,315
-34,625
-8% -$6.69M
TDOC icon
64
Teladoc Health
TDOC
$1.69B
$89.2M 0.36%
467,550
-38,281
-8% -$6.71M
PM icon
65
Philip Morris
PM
$314B
$88.5M 0.36%
1,262,964
-68,247
-5% -$4.98M
IBM icon
66
IBM
IBM
$213B
$87.8M 0.36%
760,877
-40,467
-5% -$4.7M
CME icon
67
CME Group
CME
$94.7B
$86.3M 0.35%
531,018
-101,891
-16% -$18.3M
MMM icon
68
3M
MMM
$93.1B
$85.8M 0.35%
657,468
-30,420
-4% -$3.83M
QCOM icon
69
Qualcomm
QCOM
$169B
$83.2M 0.34%
912,475
-64,994
-7% -$5.21M
REGN icon
70
Regeneron Pharmaceuticals
REGN
$73.2B
$83.2M 0.34%
133,381
+47,978
+56% +$27.2M
LOW icon
71
Lowe's Companies
LOW
$121B
$82.9M 0.34%
613,763
-43,679
-7% -$4.99M
HON icon
72
Honeywell
HON
$76.9B
$82.7M 0.34%
606,954
-46,093
-7% -$6.1M
SPLK
73
DELISTED
Splunk Inc
SPLK
$81M 0.33%
407,500
+11,164
+3% +$1.77M
BA icon
74
Boeing
BA
$167B
$79.8M 0.32%
435,310
-24,291
-5% -$3.73M
IAU icon
75
iShares Gold Trust
IAU
$62.2B
$79.1M 0.32%
2,328,420
+244,380
+12% +$8.01M

Similar funds

Chevy Chase Trust's Q2 2020 Portfolio in Review

As of Q2 2020, Chevy Chase Trust held 661 positions worth $24.7B, up 15% from $21.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Chevy Chase Trust withdrew a net $1.16B in Q2 2020, closing 20 positions and reducing 513 holdings. Its most notable exit was Allergan plc, an estimated $49.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Chevy Chase Trust opened a new position in DexCom worth $30.1M.

  • Chevy Chase Trust's largest Q2 2020 buy was DexCom: 297,088 shares worth $30.1M.
  • Chevy Chase Trust added most to RTX Corp in Q2 2020, an estimated $73.5M increase.
  • Chevy Chase Trust's biggest Q2 2020 reduction was Apple, cutting an estimated $87.1M.
  • Chevy Chase Trust fully exited Allergan plc in Q2 2020, selling an estimated $49.5M.
  • Chevy Chase Trust's ten largest holdings make up 27% of its $24.7B portfolio in Q2 2020.
  • Chevy Chase Trust opened 31 new positions and closed 20 in Q2 2020.
  • Chevy Chase Trust's portfolio value rose 15% quarter-over-quarter to $24.7B.

Based on Chevy Chase Trust's 13F filing for Q2 2020, filed 14 Aug 2020.